IP Library › Granted Patent US 8,858,925
Granted Patent B2
US 8,858,925 · App. 13/181,562 · Granted Oct 14, 2014

Pegylated fibrinogen precursor molecule

Inventors: Dror Seliktar (Haifa, IL); Liora Almany (Atlit, IL)
Assignee: Regentis Biomaterials Ltd.
A61L27/227A61L27/24A61K47/48784A61K38/363C12N2533/54A61K47/48215A61L27/18A61L27/38C12N2533/30A61K47/48292A61L27/52C12N2533/50C12N2533/40C12N2533/52C12N5/0068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,858,925
App. No.
13/181,562
Granted
Oct 14, 2014
Kind
B2
Abstract

The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.

Claims (11)

1. A precursor molecule comprising a fibrinogen protein which is denatured and retains an activity of forming a scaffold and at least two polyethylene glycol (PEG) molecules covalently connected to free thiol groups of said denatured fibrinogen protein, each of said at least two PEG molecules comprising a functional group for cross-linking.

2. The precursor molecule of claim 1 , wherein said PEG is selected from the group consisting of PEG-acrylate (PEG-Ac) and PEG-vinylsulfone (PEG-VS).

3. The precursor molecule of claim 1 , wherein said PEG-Ac is selected from the group consisting of PEG-DA, 4-arm star PEG multi-Acrylate and 8-arm star PEG multi-Acrylate.

4. The precursor molecule of claim 3 , wherein said PEG-DA is a 4-kDa PEG-DA, 6-kDa PEG-DA, 10-kDa PEG-DA, 14-kDa PEG-DA and/or 20-kDa PEG-DA.

5. The precursor molecule of claim 3 , wherein a molar ratio of PEG-DA:fibrinogen is 2-400:1.

6. The precursor molecule of claim 3 , wherein a molar ratio of PEG-DA:fibrinogen is 100-200:1.

7. The precursor molecule of claim 1 , wherein said fibrinogen protein retains an activity of mediating tissue regeneration following in vivo administration.

8. A method of generating a scaffold comprising:

(a) generating the precursor molecules of claim 1 ; and subsequently

(b) cross-linking said precursor molecules to thereby generate the scaffold.

9. A precursor molecule comprising a fibrinogen protein which is denatured and retains an activity of mediating tissue regeneration following in vivo administration, and at least two PEG molecules covalently connected to free thiol groups of said fibrinogen protein, each of said at least two PEG molecules comprising a functional group for cross-linking.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2011
From: SELIKTAR, DROR; ALMANY, LIORA
To: REGENTIS BIOMATERIALS LTD.
Reel/Frame 026841/0764 →
Continuity (4)
Continuation 11472437 · Jun 22, 2006
Continuation In Part PCTIL2004001136 · Dec 15, 2004
Provisional Application 60530917 · Dec 22, 2003
Related Publication 20120020911A1 · Jan 26, 2012